ANTHRAX
Clinical trials for ANTHRAX explained in plain language.
Never miss a new study
Get alerted when new ANTHRAX trials appear
Sign up with your email to follow new studies for ANTHRAX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New anthrax vaccine shows promise in large trial
⭐️ VACCINE ⭐️ CompletedThis Phase 3 trial tested a new anthrax vaccine called AV7909 in nearly 3,700 healthy adults. The vaccine aims to protect people after they have been exposed to anthrax bacteria. Results showed that AV7909 produced a strong immune response and was safe, similar to the current lic…
Matched conditions: ANTHRAX
Phase: PHASE3 • Sponsor: Emergent BioSolutions • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
Anthrax secrets revealed: new study tracks infection and vaccine response
Knowledge-focused CompletedThis study follows people who have or had anthrax, those exposed, and healthy vaccinated volunteers to learn how the body fights the disease. Researchers will track symptoms, immune responses, and long-term health for up to 2 years. The goal is to better understand anthrax and im…
Matched conditions: ANTHRAX
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Anthrax vaccine and antibiotics: a safety check
Knowledge-focused CompletedThis study looked at whether giving the anthrax vaccine AV7909 along with common antibiotics (ciprofloxacin or doxycycline) changes how the body processes those antibiotics. 210 healthy adults received the vaccine and antibiotics on a set schedule. The goal was to see if the vacc…
Matched conditions: ANTHRAX
Phase: PHASE2 • Sponsor: Emergent BioSolutions • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:36 UTC